Needle vs. radio waves: which zaps heel pain best?

NCT ID NCT07688876

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study compares two minimally invasive treatments for chronic plantar fasciitis—a common cause of heel pain that hasn't improved with rest or physical therapy. One group receives ultrasound-guided pulsed radiofrequency, which uses electrical pulses to disrupt pain signals; the other gets a series of 5% dextrose (sugar water) injections around the painful area. Both groups also do a home stretching program. Researchers will measure pain, foot function, and quality of life over 12 weeks to see which approach works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pulsed radiofrequency or 5% dextrose injection
What this could lead to
If one treatment proves superior, it could offer a more effective, minimally invasive option for chronic heel pain that hasn't responded to conservative care.
What could go wrong
This is a small, early-stage trial with only 50 participants, so results may not apply widely. Both procedures are experimental for this condition and carry risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEEL PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital

    RECRUITING

    Ankara, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.